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ABSTRACT 
Elucidating the relation between human milk fatty acids, extracellular vesicles, and infant 
health outcomes in the first year of life 
by Diana Claire Bickmore 
For most infants, human milk is the recommended source of nutrition. Improved developmental 
outcomes have been reported in infants that consume human milk compared to infant formula. 
Essential fatty acids (EFAs) confer health benefits. However, EFAs cannot be synthesized by the 
body, and therefore must be consumed in diet. Extracellular vesicles (EVs) are nanoparticles 
containing a lipid bilayer membrane and are present in human milk. Methods of EV isolation 
such as ultracentrifugation (UC) may not be feasible for the study of EVs in human milk due to 
the need for large sample volume, which may not be available. The objectives of this research 
were therefore to investigate i) if the concentration of essential fatty acids in milk correlated to 
infant developmental outcomes reported by the Bayley Scales of Infant Development (BSID-III) 
and ii) if an EV isolation method using a precipitation method could be optimized for isolation of 
EVs in a low volume of human milk. Human milk samples were obtained two weeks post-
partum (n=70), and corresponding developmental data was obtained. Total fatty acids from milk 
samples were quantified by Gas Chromatography-Mass Spectrometry (GC-MS). Electron 
microscopy, nanoparticle tracking analysis, and semi-quantitative antibody array were conducted 
to confirm isolation of human milk EVs. Count, size, protein content, and fatty acid 
quantification of EVs were also determined. Arachidonic acid was inversely correlated with 
Cognitive Composite scores at 12 months of age (p<0.05). The EV isolation technique yielded 
8.9 x 109 ± 1.1x 109 EV particles/mL of human milk, and meets the Minimal Information for 
 VI 
Studies of Extracellular Vesicles (MISEV) guidelines. Validation of an EV isolation protocol for 
small volumes of human milk will facilitate research in this growing area. It can be concluded 
that bioactive components of human milk are related to infant development, and future research 
on fatty acids and EVs and human milk is warranted to assist nutritional recommendations for 
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1. Bioactive Components in Human Milk: A literature review and
introduction to the present research 
Introduction 
In 2015 only about 25% of babies in the United States were exclusively breastfed for the 
first 6 months of life. The American Academy of Pediatrics recommends that infants should be 
exclusively breastfeed for the first 6 months of life (CDC, 2018). Because human milk is the 
recommended source of nutrition for infants, a greater understanding of its composition is crucial 
to public health. There is therefore a critical need to explore the associations between infant 
health outcomes, and bioactive components in human milk. This may facilitate nutritional 
recommendations for breastfeeding mothers in the perinatal period, and inform the nutritional 
composition of commercial infant formulas made to mimic the biological properties of human 
milk and human milk fortifiers designed to optimize human milk.  The present study will define 
infants as children younger than one year of age (WHO, 2013), and newborns as children under 
one month of age.  
Fatty acids in human milk have been linked to improved infant health and developmental 
outcomes. The consumption of essential fatty acids (EFA) by infants, such as docosahexaenoic 
acid (DHA) and eicosopentanoic acid (EPA) has been correlated to superior visual acuity and 
cognitive development (Makrides, Simmer, Goggin, & Gibson, 1993), and infants consuming 
infant formula fortified with DHA and arachidonic acid (ARA) scored closer to infants fed 
human milk (Lien, Richard, & Hoffman, 2018). Although human milk is the recommended 
source of nutrition for the first six months of life, the relation between bioactive compounds, 
such as essential fatty acids present in human milk and standardized developmental outcomes in 
the absence of confounding variables associated with breastfeeding remains unclear.  
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Extracellular vesicles (EV) are a type of bioactive component present in human milk that 
may confer health benefits to newborns and infants. EVs are produced by nearly every type of 
mammalian cell for cell to cell communication (De la Torre Gomez, Goreham, Serra, Nann, & 
Kussman, 2018). EVs are composed of proteins, nucleic acids, and lipids. Lipids and fatty acids 
are crucial components of extracellular membranes, and specific lipids and fatty-acid containing 
lipids such as sphingomyelin and cholesterol have been found in higher concentrations in EVs 
compared to the cell from which it was derived (Llorente et al., 2013). EVs in human milk have 
been found to mediate immune and inflammatory responses and the promotion of epithelial 
growth in the intestine. (De la Torre Gomez et al., 2018; Hock et al., 2017b).  
This gap in knowledge may exist partly due to the difficulty of isolating EVs. Although 
ultracentrifugation (UC) is the “gold standard” technique for the isolation of EVs, it requires 
sample volumes in excess of several mL, and may result in the co-isolation of contaminants like 
albumins and immunoglobulins (Caradec et al., 2014). Using a large sample volume for isolation 
of EVs from human milk is often not feasible, as the milk is needed to feed the infant, and 
mothers may not lactate sufficient excess volumes to be collected for research. The necessity of 
large sample volumes of human milk for research purposes relegates researchers to only studying 
mature milk. This hinders the study of variation over i) early, transitional and mature milk 
production periods, ii) course of lactation (fore vs. hind milk), and iii) time-of-day.   
The overarching goals of this project were to correlate the fatty acid composition of 
human milk and human milk EVs to infant health and development (Cognitive, Behavioral, and 
Motor) outcomes reported by the Bayley Scales of Infant Development (BSID-III). It was 
hypothesized that bioactive components in human milk are related to developmental outcomes in 
infants. To investigate this hypothesis, essential fatty acids were correlated to BSID-III 
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outcomes. Determining the relation between the fatty acid content of EVs in human milk and 
infant developmental outcomes was not feasible due to the lack of a suitable EV isolation 
method. Therefore, the second objective became to optimize an EV isolation method for low (<2 
mL) volumes of human milk to facilitate the study of EV composition and infant health and 
developmental outcomes in future research.  
Review of Literature 
Nutritional benefits of human milk  
For most infants, human milk provides the best source of nutrition and benefits the health of both 
mothers and infants, reducing risk for short and long-term health conditions include asthma, 
obesity, Type II diabetes, ear and respiratory infections, and gastrointestinal infections (CDC, 
2018). Infants consuming human milk benefit epidemiologically from protection against illness 
and infection due to specific and non-specific immune factors found in human milk (Oddy, 
2002); protective components in milk such as secretory IgA antibodies and lactoferrin confer 
immunity against common infections to breastfed infants (Hanson et al., 2003). The benefits of 
consuming human milk may also extend beyond infancy. (Wilson et al., 1998) investigated the 
correlation between exclusive consumption of human milk in infancy and childhood respiratory 
illness, growth, and body composition, and found that infants who were exclusively fed human 
milk for 15 weeks (compared to infants partially fed human milk for 15 weeks and formula fed 
infants) experienced lower incidences of respiratory illnesses and wheezing during childhood, as 
well as lower percentages of body fat and weight, indicating less risk of childhood obesity. 
Consumption of human milk has even been correlated with lower rates of Attention-
Deficit/Hyperactivity Disorder (ADHD) in children (Mimouni-Bloch et al., 2013). Despite the 
multitude of short and long-term benefits associated with consuming human milk, the majority of 
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infants do not consume human milk exclusively for as long as recommended by the World 
Health Organization and American Academy of Pediatrics, with only 1 in 4 exclusively breastfed 
for 6 months (CDC, 2018). 
Variability of fatty acid composition of human milk 
Human milk is widely considered more nutritious for infants than infant formula. 
Studying the composition of human milk can therefore help create more nutritious infant formula 
products. The fatty acid composition of human milk was examined using gas-liquid 
chromatography and spectrophotometry (Insull & Ahrens, 1959). It was found that human milk 
fatty acids consisted of: oleic (29%), palmitic (21%), myristic (9%), linoleic (7 %), stearic (7 %), 
lauric (7 %), isooleic (7 %), palmitoleic (2 %), and other species in minor quantities. More 
recently, meta-analyses have compared the composition of human milk fatty acids at similar 
points of lactation worldwide (Barreiro, Díaz-Bao, Cepeda, Regal, & Fente, 2018), and fatty 
acids present in smaller amounts have been quantified. Comparing 21 studies of the fatty acid 
composition of human milk worldwide to the composition of human milk in Galicia, Spain, it 
was found that worldwide, fatty acid profiles of human milk were similar, with the exception of 
several Asian countries (Barreiro et al., 2018). Women in Asian countries where consumption of 
marine products is high had elevated levels of DHA in milk. While maternal diet is a well-known 
factor that alters the fatty acid composition of human milk, other variables that may influence the 
fatty acid composition of human milk have also been investigated. In a study of 71 Australian 
infants exclusively consuming human milk, it was suggested that the average fat content was 
independent of the gender of the infant, and that the mean fat content of milk was significantly 
(p<0.001) related to the time of day, with the mean fat content of the milk collected in the day 
and evening (42.8 ± 9.1 and 43.2 ± 9.1 g/L, respectively) being higher than the milk collected in 
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the morning and at night (37.1 ± 10.1 and 37.2 ± 10.3 g/L, respectively), which was likely due to 
more milk being removed during the day and evening from feedings  (Kent et al., 2006).  
Essential fatty acids, and fatty acid desaturase 
Omega-3 and omega-6 are classes of polyunsaturated fatty acids (PUFAs) consisting of at 
least one cis-double bond (Food and Nutrition Board, 2002). In omega-6 fatty acids, the last 
double bond is situated between the sixth and seventh carbon atom from the methyl end of the 
fatty acid, and in omega-3 fatty acids, the last double bond is situated between the third and 
fourth carbon atom from the methyl end of the fatty acid. The two precursors to long chain 
polyunsaturated fatty acids (LC-UPUFAs) are linoleic acid (LA) and alpha-linolenic acid (ALA) 
(Figure 1-1). LA (18:2n-6) and ALA (18:3n-3) have no known biological activity. LA and ALA 
are essential because they cannot be synthesized by humans, meaning they must be consumed in 
diet to prevent nutritional deficiency. Although humans are able to synthesize saturated fatty 
acids and monounsaturated fatty acids from acetyl coenzymeA, humans are not able to 
synthesize EFA because they do not have the enzymes needed to add a cis-double bond at the n-
3 or n-6 position. Long-chain omega-3 and omega-3 products docosahexaeonoic acid (DHA) and 
arachidonic acid (AA) respectively can be synthesized from their ALA and LA precursors 





Figure 1-1. Chemical structures of linoleic acid (a) and alpha-linolenic acid (b), the two precursor 
essential fatty acids. Created with ChemDraw 18. 
Deficiencies in EFA have been associated with decreased growth in children and infants, 
greater susceptibility to infections, and slower wound healing (Jeppesen, Høy, & Mortensen, 
1998). Omega-3 and omega-6 PUFAs are structural components of plasma membranes, and can 
influence membrane properties including fluidity, permeability, and activity of membrane-bound 
enzymes (Nakamura & Nara, 2004). However, there is inter-individual variability in the 
metabolism of fatty acids. The FADS-1 and FADS-2 enzymes modulate the synthesis of ARA 
and DHA from LA and ALA. Polymorphisms in the FADS-1 and FADS-2 genes encode the 
enzymes that alter the production and thus concentration of LC-PUFAs (Lattka, Illig, Heinrich, 
& Koletzko, 2009) for consumption in human milk. Therefore, fatty acid content of infants and 
newborns consuming  human milk as well as maternal FADS genotype may impact health 
outcomes of newborns and infants.  
Fatty acids in infant formula and human milk 
 DHA and ARA are conditionally essential fatty acids since (Larque, Demmelmair, & 
Koletzko, 2002) infants are able to synthesize DHA from ALA and ARA from LA. However, 
infants are not able to synthesize sufficient amounts to maintain cellular and plasma DHA 
concentrations without consuming additional DHA from diet (Larque et al., 2002). When infants 
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consume pre-formed ARA and DHA in human milk, they exhibit higher plasma and tissue 
phospholipid levels than babies that consume infant formula. It has therefore been proposed that 
infant formulas be fortified with DHA so the cellular and plasma DHA levels of formula fed-
infants could reach those of infants consuming human milk (Larque et al, 2002). ARA is 
typically less varied in human milk than DHA (Carlson & Colombo, 2016). 
 Like DHA, ARA has been associated with infant growth and development. Higher levels 
of erythrocyte phospholipid ARA concentrations in infants were correlated to increased growth 
(weight and length) at 2, 4, 6.5, and 9 months of age (Carlson, Werkman, Peeples, Cooke, & 
Tolley, 1993), and infants consuming human milk and infants consuming formula supplemented 
with DHA and ARA were found to have better visual acuity at 2 months of age (Carlson, Ford, 
Werkman, Peeples, & Koo, 1996). Although infants have the ability to synthesize ARA and 
DHA from the precursors, infants consuming human milk with lower concentrations of ARA and 
DHA, and infants consuming infant formula that is not fortified with ARA and DHA may still 
experience deleterious health impacts due to the inherent inefficiency of ARA and DHA 
conversion. The negative implications associated with ARA and DHA deficiency during infancy 
warrant further consideration for infants fed human milk and formula.  
Infant health in relation to maternal diet 
The milk composition of indigenous women in Bolivia was examined. Milk samples of 
Bolivian women were compared to samples from women in the United States at corresponding 
lactational stages to compare the fatty acids (M. Martin et al., 2012). It was found that the 
percentages of ARA, DHA, total n-3 and total n-6 LCPUFAs were significantly greater in the 
indigenous women. This was likely due to their traditional diet including higher consumption of 
wild game, freshwater fish, and a limited consumption of processed foods and oil. These findings 
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have important implications for maternal nutrition. If the fatty acid composition of human milk 
can be easily altered by diet, women can consume diets that would result in a favorable fatty acid 
composition of milk. Alternatively, human milk fortifiers could be utilized to compensate for 
dietary deficiencies. 
Maternal nutrition is important for breastfeeding mothers, since maternal diet impacts the 
composition of human milk. Perinatal nutrition has acute and chronic impacts on immunity and 
metabolism in newborns, babies, infants and children (De la Torre Gomez et al., 2018). Maternal 
protein intake is positively correlated with lipid concentration of human milk after 16 weeks 
postpartum (Nommsen, Lovelady, Heinig, Lönnerdal, & Dewey, 1991). Additionally, in a 
randomized control trial in which mothers were assigned to either a placebo or DHA-
supplemented group, the DHA concentrations in the milk of the supplemented group 
significantly (p<0.05) increased (Valentine et al., 2012) over time relative to the placebo group. 
This evidence reaffirms that the presence of specific fatty acids in maternal diet alters the fatty 
acid composition of human milk, and that maternal nutrition impacts the composition of human 
milk.  
Standardized health and behavioral tests for infants  
The Bayley Scales of Infant Development 
The BSID-III is an individually administered test to measure developmental functioning of 
infants and toddlers. The test identifies developmental delay and accelerated developmental 
trajectories and tracks a child’s developmental progress. The BSID-III can be administered to 
children between 1 and 42 months of age. The BSID-III is comprised of Cognitive, Language, 
Motor, Social-Emotional, and Adaptive Behavior Scales (Bayley, 2006), and includes activities 
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such as pretend play, novelty preference, habituation, and number ordering. Based on the 
composite scores in the various scales, the test identifies signs of developmental delay and 
advanced developmental trajectories. To that end, the primary goal of the Bayley-III is simply to 
identify whether or not children are experiencing developmental delay, not to provide a specific 
diagnosis for a disorder (Albers & Grieve, 2007). The BSID-III was designed to be simpler with 
respect to the administration of the test. Scoring is less ambiguous than in previous editions, as 
the only possible scores recorded by examiners trained in developmental interpretation and 
assessment are 0 and 1 (no credit and credit respectively). Typically a caregiver remains present 
in the room during administration of the BSID-III to ensure accurate representations of the 
infant’s optimal performance and prevent negative behavioral reactions that may stem from 
separation. The chronological age of the child being examined corresponds to a designated 
starting point for Cognitive, Motor, and Language scales, and scoring is discontinued if five 
consecutive items are given no credit (Albers & Grieve, 2007).   
Of the five scales that comprise the BSID-III, the following three are administered by the 
clinician: Cognitive, Motor, and Language. Specifically, the Cognitive scale assesses play skills, 
information processing related to attention to novelty and memory, and problem-solving, 
counting, and numerical skills. The Language Scale assesses receptive and expressive language 
to examine communication skills, and the Motor Scale examines both Fine and Gross Motor 
skills (Bayley, 2006).  
Standardized health and developmental outcomes in relation to human milk 
Human milk is considered the optimal source of infant nutrition for newborns. However, 
there is a lack of information correlating standardized measures of health and developmental 
outcomes to the composition of human milk. There is also a lack of information correlating 
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specific bioactive components of human milk, such as fatty acids, to these outcomes. Although 
human milk consumption has been correlated with increased cognitive functioning in infants, 
many of the correlations found between consumption of human milk and superior cognitive 
functioning may be confounded by other factors associated with breastfeeding such as maternal 
socioeconomic class and intelligence quotient (IQ) (Walfisch, Sermer, Cressman, & Koren, 
2013).  
Although specific fatty acids, such as DHA and AA, have been associated with cognitive 
benefits when used as ingredients in infant formulas (Larque et al., 2002), the benefits associated 
with bioactive components of human milk are also often limited by confounding factors. Various 
experiments have only been designed to correlate newborns fed human milk to those fed infant 
formula with particular health and behavioral outcomes, meaning the actual composition of the 
human milk that breastfed infants consume is not taken into account.  
In a study of 771 low birthweight infants, babies whose mothers provided human milk 
instead of formula exhibited greater mean Bayley developmental index scores even after 
adjusting for demographic and perinatal factors (Morley, Cole, Powell, & Lucas, 1988). 
Likewise, after adjusting for the several confounding factors, including maternal age, 
intelligence, education, and smoking status during pregnancy, it was found that infants fed 
human milk scored higher on the Bayley mental development index (MDI) at 13 months of age if 
they had been fed human milk for six months after birth instead of fewer than three months 
(Angelsen, Vik, Jacobsen, & Bakketeig, 2001). The present study will build upon the prior 
knowledge correlating consumption of human milk to particular health and behavior outcomes 
by correlating specific bioactive components of human milk, such as fatty acids, instead of 
human milk as a whole, to health and behavioral outcomes.  
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The BSID-III was used to compare infants fed  formula exclusively and infants fed both 
human milk and formula, as well as infants fed human milk exclusively in bottles versus human 
milk directly from the breast (Pang et al., 2019). It was found that infants who were bottle-fed 
human milk exhibited significantly better Cognitive scores on the BSID-III at 2 years than 
infants only fed infant formula. Interestingly, compared to the infants who were bottle-fed 
human milk, infants who consumed human milk by breastfeeding achieved higher scores on 
several memory tasks. Thus, confounding factors such as the discrepancy in the BSID-III scores 
between infants that were breastfed and bottle-fed human milk emphasize the importance of 
relating specific components found in human milk to test outcomes, and highlight that results 
from infants consuming human milk administered differently should not be considered 
analogous.  
Description and significance of extracellular vesicles 
EVs were first described in 1983 as vesicles secreted by red blood cells, but became of 
interest to immunologists when it was discovered (Raposo et al., 1996) that cells of the immune 
system could secrete exosomes when multivesicular bodies (MVBs) fused with the plasma 
membrane (Bobrie, Colombo, Raposo, & Théry, 2011). The term “exosome” was proposed to 
refer to the extracellular vesicles that originated from intraendosomal regions of mammalian 
cells (Johnstone, Adam, Hammond, Orr, & Turbide 1987).  
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Figure 1-2. Formation and release of exosomes from cells. Figure (Skotland, Sandvig, & 
Llorente, 2017) reprinted from the PhD degree of Santosh Phuyal, University of Oslo.  
Exosomes are membrane vesicles enclosed in a lipid bilayer.  These nanoparticles are 
released by most mammalian cell for intercellular communication, and are unique to the cell in 
which they originate (De la Torre Gomez et al., 2018). EVs circulate in human biological fluids 
such as blood, urine, saliva, and human milk (De la Torre Gomez et al., 2018). There are three 
steps in exosome biogenesis: biogenesis of MVBs, the transport of MVBs to the plasma 
membrane, and the fusion of the MVBs with the plasma membrane (Figure 1-2), which releases 
the intraluminal vesicles from the MVBs. Exosomes are the smallest of the three types of EVs, 
the other two being microvesicles and apoptotic bodies (T Skotland et al., 2017).   
The function of EVs was further emphasized due to their touted role in cancer 
progression. In lung cancer, platelet derived microvesicles transferred an integrin (CD41) to 
numerous lung cancer lines, eliciting the highest response in highly metastatic cells, which 
indicated the significance of extracellular vesicles in disease pathology (Janowska-Wieczorek et 
al., 2005). EVs contain microRNA and messengerRNA. When mouse EV-derived RNA was 
transferred to human mast cells, new mouse proteins were found in the recipient cells, indicating 
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that the transferred mRNA was able to be translated after entering a new cell (Valadi et al., 
2007).  Bovine milk derived EVs were used for drug delivery because EVs from bovine milk can 
be obtained more cost-effectively and on a larger scale  (Munagala, Aquil, Jeyabalan, & Gupta, 
2016). Bovine milk EVs were also found to have cross-species tolerance; when mice possessing 
human lung cancer (A549) xenografts were treated with the cancer drug Withaferin A (WFA) as 
free-WFA or exo-WFA (drug-loaded EVs), the exo-WFA exhibited a significantly greater tumor 
inhibitory effect (46% vs 23%) than the free WFA (Munagala et al., 2016).  
Given the public health importance of cancer and drug research, the study of EVs in other 
fields has been neglected. For example, (T Skotland et al., 2017) analyzed approximately 280 
lipid species in the metastatic prostate cancer cell line PC-3 (Llorente et al., 2013) and stated that 
to their knowledge, the only study providing quantitative data for both the parent cell and 
exosomal lipid composition of more than  just a few lipid species was their own, which still 
holds true. There is therefore a general gap in knowledge regarding the application of EVs to 
other fields such as nutrition. There is also limited knowledge on fatty acid constituents of 
extracellular vesicles, which may be involved in cellular processes such as EV release and 
formation.  
Lipids and fatty acids in extracellular vesicles 
Lipids in the plasma membrane may influence the formation and release of the EVs 
during the biogenesis of EVs. Compared to the cell from which it is derived, lipids such as 
cholesterol and sphingomyelin are enriched in EVs (Llorente et al., 2013). The intraluminal 
vesicles of multivesicular endosomes are sorted into lysosomes for degradation of cargo, or 
secreted as EVs (Trajkovic et al., 2008), a process that is dependent on the composition of lipids. 
It was found that the transfer of exosome-associated domains into the lumen of the endosome 
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required the sphingolipid ceramide, which implicated lipids in the formation and subsequent 
communication functions of EVs (Trajkovic et al., 2008). EV synthesis, release and transport 
occur in a highly regulated manner and thus it is plausible that alteration of lipids composition of 
EV may alter function. 
A study quantifying over 217 lipids in the EVs of PC-3 cells showed differences in the 
relative proportion of lipids of EVs compared to the cells of origin (Llorente et al., 2013). The 
total lipid concentration in protein was 94.2 ± 6.8 in PC-3 cells and 790.7 ± 68.5 in nmol/mg in 
EVs, indicating a greater-than 8-fold enrichment of lipids into EVs per mg protein (Llorente et 
al., 2013). Additionally, it was discovered that the relative proportions of glycosphingolipids, 
cholesterol, sphingomyelin (SM), and phosphatidylserine (PS), was over 15 times higher in the 
EVs than in the cell of origin (Llorente et al., 2013). The membrane of EVs is highly ordered, 
and the high composition of glycosphingolipids in EVs likely confers EVs with stability in 
extracellular environments, which is essential for their role in cell-to-cell communication. Lipids 
in EVs have also been associated with biogenesis and communication due to the presence of 
lipid raft associated proteins such as flotillin-1; lipid rafts are areas of the plasma membrane rich 
in cholesterol and glycosphingolipids (de Gassart, Geminard, Fevrier, Raposo, & Vidal, 2003). 
The tetraspanins CD9 and CD81 have also been found to be physically and functionally linked 
with cholesterol; tetraspanins are believed to form a tetraspanin “web” of molecular interaction. 
Tetraspanin/tetraspanin complexes were precipitated using digitonin, a cholesterol precipitating 
reagent (Charrin et al., 2003). Due to the interaction of tetraspanin with cholesterol, it was 
postulated that tetraspanins in EVs may be attributed to the association with lipid rafts 
(Brzozowski et al., 2018).   
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Inconsistency in  methods of EV isolation and analysis have hindered the acquisition of 
knowledge pertinent to the significance of the lipid composition of EVs (T Skotland et al., 2017). 
Results from the different techniques are dependent on not just the method used, but also the 
purity of the samples being analyzed (T Skotland et al., 2017). Additionally, lipids present in 
EVs isolated from different biofluids vary, including EVs from the same biofluid in healthy 
controls and diseased patients (Table 1-1). Consistent isolation and characterization methods for 
EVs and constituents of EVs from different biofluids, including complex matrices such as human 
milk, are therefore necessary to understand the specific function of lipid compositions that have 
been observed in lipid bilayers of EVs. Although the present study does not explore the 
composition of fatty acid-enriched fractions of EVs, the validation of an isolation method for EV 
isolation in human milk will facilitate such future studies on the structure and functional 
significance of EVs in human milk.
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Table 1-1. Summary of lipids and fatty acids in EVs in the literature. 
Origin of 
EVs 
Type of Lipid(s) 
Studied 
Focus of Study Key Findings and Conclusions Citations 
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Of the 107 lipid species, 36 of the 
most common lipid species were 
further analyzed, 9 of which 
significantly differed between 
cancer patients and healthy controls. 
Lipids in urinary exosomes may be 
useful as biomarkers for prostate 
cancer since the high patient: 
control ratio of specific lipids such 
as phosphatidylserine distinguished 
the cancer patients from controls. 
(T. Skotland 
et al., 2017) 
Exosomes 







Since lipids are key 
constituents of 
exosomes given that 
the lipid bilayer of 
Plasmalogens and other classes of 
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exosomes secreted by 





MS/MS) was used for 
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parasitic exosomes was observed 
compared to the murine exosomes. 
Analyses of exosomal membrane 
dynamics indicated the membrane 
of the nematode was more rigid. 
The parasite may maintain rigidity 
of the exosomal membrane from 
increased plasmalogens compared to 
other lipids, plasmalogens are 
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CD36 (SR-B2) and 
FATP4 in obese 
males with type II 
diabetes and obese 
male controls.  
Nielsen et al. (2019) found a 
positive correlation between 
SKMVs carrying CD36 and 
performance of acute exercise only 
in males with type II diabetes.  The 
authors conclude that studying 
LCFA transport protein released by 
EVs in “real-time” could be key to 
understanding LCFA uptake in 







Isolation of EVs, quantification, and verification 
 
A  variety of methods can be used to isolate exosomes. However, there are trade-offs 
associated with each method. Table 1-2 summarizes the applications of common EV isolation 
methods, indicating advantages and disadvantages of methods for different applications. A 
commercial kit makes sense technically for applications where there is a high sample number, 
and low volume for each sample. 
 
Table 1-2. Summary of the applications of different exosome isolation techniques.  
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(Pedersen et al., 
2015) 
 The optimal method of EV isolation may vary depending on the specimen from which 
the EVs are isolated. It is therefore important to consider the methods utilized for EV isolation 
when interpreting the results of a study. To isolate EVs using differential UC, initial steps 
eliminate large dead cells and cell debris by centrifuging at increasing speeds, discarding the 
pellet and keeping the supernatant. The final pellet, which appears after centrifuging at 100,000 x 
g, contains the exosomes, and is washed in phosphate buffered saline (PBS) and centrifuged one 
more time to eliminate contaminating proteins (Thery et al., 2006). Although UC is the most 
commonly used EV isolation method (Sáenz-Cuesta et al., 2015; Xin Wang, 2017; Yamada, 
Inoshima, Matsuda, & Ishiguro, 2012), it can result in the co-isolation of exosomes, lipoparticles, 
and lipid droplets, which alters the lipid composition of EVs as opposed to isolating exosomes 
with a typical membrane bilayer (T Skotland et al., 2017). Therefore, if the downstream 
application of exosome isolation involves lipid analysis, another method of isolation, such as a 
commercial kit should be used instead.  
UC has been considered the gold-standard for exosome isolation due to its perceived ease 
of use and affordability (Li, Kaslan, Lee, Yao, & Gao, 2017). However, UC is time-consuming, 
requires large volumes of biofluid and specialized equipment, and EVs isolated by UC may also 
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be contaminated by proteins (Caradec et al., 2014). The isolation of EVs using UC was 
compared, and it was discovered that centrifuging at different speeds impacts the purity and yield 
of the EVs that are isolated, since undesirable contaminants such as protein aggregates may 
sediment similarly to EVs (Jeppesen et al., 2014). It was found that the optimal speed for purity 
and yield differed between two cell lines. Therefore, when a standard UC protocol is utilized to 
isolate EVs from a variety of biofluids, it may not be optimized to collect EVs with the greatest 
purity and yield from human milk. 
 Other methods of EV isolation include precipitation-based methods and 
immunoprecipitation. Combination methods, such as UC followed by use of a commercial kit 
can also be performed. One precipitation method works by using a proprietary polymer reagent 
that precipitates EVs between 30 and 200 nm. According to the manufacturer, the kit eliminates 
the trade-offs of yield, purity, and speed, and it can be used with as little as 250 μL of specific 
biofluids (SBI, 2018c). However, the commercial kits available have not been authenticated for 
use of human milk; ExoQuick® is recommended for plasma, serum, and ascites fluid, while 
ExoQuick® TC is recommended for isolating EVs from tissue culture (SBI, 2018c). 
 21 
Figure 1-3. Comparison of UC with a commercial kit for isolation of EVs in human milk. UC adapted 
from (Thery et al., 2006) and ExoQuick TC ™(Xin Wang, 2017).  
Sample collection 
Defat milk (centrifuge 2000 x g for 
10 min)  
Centrifuge 10,000 x g for 30 min 
Keep supernatant: pellet = cell 
 
Ultracentrifuge 100,000 x g for 70 min 
Pellet= exosomes + contaminating 
proteins 
Wash in 1 X PBS and ultra
 
centrifuge 
100,000 x g for 70 min
Pellet = exosomes 
Defat milk  
(centrifuge 2000 x g for 10 min) 
then 3,000 x g for 15 min  
Sample collection
Centrifuge supernatant at 12,000 
x g for 30 min and discard 
debris; filter 
Add ExoQuick TC ™ and 
incubate overnight at 4 oC
Centrifuge at 5,000 x g for 
30 min, and re-suspend in 
1X PBS 
 
If desired, purify further 
with ExoQuick TC ™
b. Commercial Kita. UC
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When isolating EVs, the downstream application and need for intact structure and high 
yield must be considered. Using ExoQuick®  precipitation, UC with ExoQuick®  precipitation, 
and UC with density gradient centrifugation, and a protocol for isolating EVs in human milk 
(Admyre et al., 2007) with bovine milk, it was found that the human milk isolation protocol 
failed to isolate EVs from the bovine milk using the ExoQuick®, as they were unable to suspend 
the final EV pellet in PBS for storage due to interference of precipitating proteins (Yamada et al., 
2012). The method was unsuccessful, because the de-fatted bovine milk could not be filtered, 
perhaps due to the greater protein content of bovine milk, which clogged the filter. Therefore 
subsequent isolation steps could not be performed. UC with ExoQuick® and precipitation 
resulted in the highest yield, while density gradient centrifugation resulted in higher quality EV 
isolation, with more intact morphological structures, as visualized by electron microscopy. Given 
the advantages and disadvantages of each method, the downstream application should be 
considered when choosing a method. For example, to analyze total fatty acid content in human 
milk, yield is more important than obtaining intact vesicles. 
The increased recovery associated with UC and ExoQuickTM precipitation relative to EVs 
isolated with UC and density gradient centrifugation may be useful to analyze mRNA kinetics or 
exosomal proteins (Yamada et al. 2012). Conversely, the higher purity isolations from UC with 
density gradient centrifugation relative to UC and ExoQuickTM precipitation may be more 
appropriate for analysis of exosomal proteins. The Yamada et al. (2012) study highlights the 
importance of selecting an EV isolation technique based on careful consideration of the type of 
specimen from which EVs are being isolated, as well as the downstream application and targeted 
use.  
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EV verification and quantification methods 
After isolating EVs, methods used for verification include immunoblot and electron 
microscopy. Immunoblot has been used to confirm EV isolation by detecting the presence of EV 
markers such as CD133 and CD63 (J. Kim, Tan, & Lubman, 2015; Sáenz-Cuesta et al., 2015; 
Yamada et al., 2012) and the absence of cellular contamination (SBI, 2018a). Using electron 
microscopy, EV isolation can be confirmed by observing the characteristic size and shape of the 
vesicles (Lobb et al., 2015; Samuel et al., 2017; Sáenz-Cuesta et al., 2015). 
Nanoparticle Tracking Analysis (NTA) is used to measure particle size and concentration 
and confirm the isolation of EVs (Hock et al., 2017). EV quantification is also performed using 
the Bicinchoninic Acid (BCA) protein quantification assay (Thermo Scientific, IL, USA). This 
method makes the assumption that protein concentration correlates positively with the 
concentration of EVs. The amount of EV protein positively correlates to a greater volume of 
biofluid (J. Kim et al., 2015), which supports this assumption. However, this assumption is a 
limitation because the relative abundance of EVs between different types of specimen or 
between isolation methods cannot be inferred.  
Measuring protein concentration in EVs is not always an accurate method of EV 
quantification although it has been frequently used. EVs isolated with UC were shown to have a 
high albumin content compared to EVs isolated with a precipitation method, impairing the 
utilization of protein quantification as a way to accurately quantify EVs (Caradec et al., 2014). EV 
protein content quantified with BCA correlated with serum volume in EVs isolated with UC and 
a precipitation method (Caradec et al., 2014). However, when NTA was used to quantify 
nanoparticles, there was no correlation between the particle number isolated by UC and the original 
volume of serum. This suggests that albumin concentration confounded the protein concentration 
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measurements. Only  comparing the protein contents of EVs isolated with the same technique can 
help eliminate the issue of misleading protein quantification results Additionally, EV confirmation 
and quantification methods may be more suited to a particular biofluid; for example, it was found 
that detection of CD133 markers for Western blot was better with EVs from urine than from blood 
(Sáenz-Cuesta et al., 2015).  
Functions of milk EVs 
EV isolation techniques for human milk need to account for components of the milk 
matrix, such as proteins, which could influence the success of an isolation technique. 
Additionally, if comparing EVs isolated from milk separately, the timing of obtaining the milk 
post-partum should also be considered. Human milk EVs from early and mature human milk 
were compared, investigating the influence of lifestyle and allergic sensitization on the profile of 
the EVs (Torregrosa Paredes et al., 2014). There were higher levels of HLA-DR antibodies and a 
lower concentration of EV protein and a lower number of vesicles in early milk (days 3-8 
postpartum) than in mature milk (two months postpartum). These differences in EV composition 
and quantity throughout lactation should be considered according to the downstream analysis.  
It was also found that there were over 4980 more proteins implicated in immune response 
and growth in EVs from bovine colostrum that were not present in mature milk. They were 
significantly enriched (p < 0.05) with Rab proteins known for their role in vesicle docking and 
fusion as well as with proteins associated with the innate immune response (Samuel et al., 2017). 
Further research on these findings may be important to determine if the same differences in 
proteins occur in human colostrum and mature milk. Commercially, this knowledge is an 
important consideration so manufacturers of infant formula can make consistent products. 
Likewise, it was concluded that processing of milk by dairies significantly results in loss of 
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miRNAs; pasteurization and homogenization of whole milk decreased miR-200c concentration 
63 ± 28% (Howard et al., 2015). Loss of miRNA during homogenization was attributed to lysis 
or disruption of EV membranes caused by the shear force applied during homogenization 
(Howard et al., 2015). MiRNA loss is problematic, as EVs are involved in cell-to-cell 
communication with their cargo, which can include miRNA (Munagala et al., 2016).  
In addition to regulation of immune response and inflammation, EVs in milk promote 
epithelial growth in the intestine, perhaps because the phospholipid membrane allows the 
contents of EVs to reach the intestinal lumen of neonates (Hock et al., 2017a). Necrotizing 
enterocolitis (NEC) is the most common gastrointestinal emergency in newborns, and 
consumption of human milk has been associated with decreased risk of NEC. The impact of milk 
derived EVs on intestinal epithelial cell viability was therefore investigated. Utilizing 
Exoquick™ reagent, EVs were isolated from rat milk and a rat small intestine epithelial cell line 
(IEC-18) was treated with 0.5-μg/μl EVs, EV-free milk, or an EV-free control solution, finding 
that the cells treated with EVs significantly increased IEC viability measured using a 
colorimetric assay compared to EV free milk and the control (p < 0.05) (Hock et al., 2017a).  
Challenges in the study of human milk EVs 
Human milk is frequently refrigerated at 4 °C or frozen at -20  for feeding infants, and at
-80 °C for research purposes and milk banking. Studying human milk samples that were
processed immediately after they were obtained and samples stored for two hours at 4 °C, -20
and -80 °C temperatures, it was discovered that the number of viable cells collected immediately
was donor dependent (Zonneveld et al., 2014). It was found that cell death and subsequent 
formation of cell debris impacted the total pool of milk EVs. This could be problematic because 
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contamination of the native milk EV with storage-induced EVs can occur if storage induced 
stress or cell death induces the formation of new EVs. The disintegration of dead cells can result 
in the formation of membrane-enclosed vesicles (Zonneveld et al., 2014). Human milk was 
spiked with cells of murine origin to track the formation of storage induced EVs. EVs were 
either isolated from the milk right away or stored at -80 °C. A ten to one hundred fold increase in
the murine CD9 and up to a 2,000% increase in murine MHC Class II EV markers stored at -
80 °C was observed compared to the immediately processed samples. This suggests the presence
of a newly formed pool of vesicles released by cells during storage that contaminated the pool of 
EV naturally occurring in milk (Zonneveld et al., 2014).  
Although the Zonneveld et al. (2014) study raises important considerations for 
researchers, it is not feasible to eliminate these concerns when researching human milk, as the 
only way to do so would be to isolate and study EVs immediately after a mother produced milk. 
Some commercial EV isolation kits require an overnight incubation step at 4 oC, and it was 
found that the viable cells were decreased after only two hours (Zonneveld et al., 2014). Because 
it is not feasible to complete all the necessary analyses and avoid storage of human milk, 
consistency is crucial, meaning any aliquots of human milk that are compared should have 
undergone identical freeze-thaw processes. 
In summary, EVs in human milk may have important functions like mediation of 
inflammatory, immune, and epithelial responses. Since lipids and lipid metabolizing enzymes 
take part in EV release and formation, fatty acid content may dictate the function of EVs. 
However, in order to even carry out structure and function research, a consistent EV isolation 
technique suited for the specimen being studied and downstream application is needed. Although 
use of a commercial isolation kit to isolate EVs from human milk is a viable option, this method 
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has not yet been validated for human milk. Therefore, before structure and function of EVs can 
be explored to benefit manufacturers of commercial infant formula products and breastfeeding 
mothers, it is crucial that this isolation method is validated for future use.  
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2. Rationale and significance
Although human milk is the recommended source of nutrition for most infants, there are
a variety of reasons a parent may need to feed with commercial infant formula to supplement or 
replace human milk. Thus, understanding if and how bioactive components of human milk 
provide optimal nutrition for infants represents a public health interest that is particularly 
relevant to parents and commercial manufacturers of infant formula seeking to replicate the 
unique benefits of human milk in products. The present study will address this public health 
issue by building upon the established knowledge that fatty acid deficiency has been linked to 
deleterious health outcomes, and that the development of a suitable isolation technique for EVs 
in human milk has hindered advances in research regarding structural and functional 
applications.    
It was hypothesized that bioactive components in human milk are related to health 
outcomes. The hypothesis was tested through the following objectives:  
(1): Determine whether fatty acid composition of milk relates to infant developmental 
outcomes reported by the BSID-III.  
 (2): Develop a feasible method of EV isolation from human milk that satisfies the 
International Society of Extracellular Vesicles (ISEV) criteria.  
This project has widespread clinical and public health implications, as it could impact 
maternal nutrition guidelines in the perinatal period. The proposed research will also contribute 
to the product development sector. It is widely accepted that commercial infant formula is 
inferior to human milk with respect to several health outcomes. Therefore, if fatty acids in 
human milk are correlated to superior developmental outcomes corroborated by standard tests, 
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the results of the proposed study can help product developers ameliorate the nutritional quality of 
their infant formula. Furthermore, this project will improve knowledge on EV isolation in human 
milk, which has not been studied as extensively as EV isolation in other biofluids such as blood 
and urine. If the results of the proposed study indicate that the essential fatty acid composition of 
EVs in human milk and the fatty acid composition of human milk are associated with favorable 
infant health outcomes recorded by standardized health tests, this could pave the way for 
maternal dietary recommendations that would favorably manipulate the fatty acid composition of 
human milk and EVs in milk.            
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3. The relation between the fatty acid composition of human milk and
BSID-III developmental outcomes
Introduction 
Human milk is the recommended source of infant nutrition for the first six months of life 
(CDC, 2018). The consumption of human milk compared to infant formula has been correlated 
with numerous short and long-term benefits, including immune system development, reduced 
risk of gastrointestinal and respiratory diseases, superior cognitive development, and reduced 
risk of chronic diseases such as diabetes, obesity, and hypertension (Vergilio Visentainer et al., 
2018). Specific benefits of human milk, such as cognitive benefits, have been linked to long 
chain fatty acids such as DHA and ARA, which make up about 20% of the brain’s fatty acid 
content and are involved in neurodevelopment (Pang et al., 2020). The omega-3 and omega-6 
PUFAs are important for human health, growth, and development. Infants consuming colostrum 
higher in linoleic acid and lower in DHA exhibited lower IQ scores at five to six years of age 
(Bernard  et al., 2017). Omega-3 PUFAs are derived from alpha linolenic acid (ALA, 18:3n-3), 
while omega-6 PUFAs are derived from linoleic acid (LA, 18:2n-6). Because the precursor 
molecules ALA and LA cannot be endogenously synthesized by humans, they are considered 
essential. Longer chain fatty acids are synthesized very slowly from the precursor molecules. 
Less than 0.1% of LA is converted into ARA (Heaton, Meldrum, Foster, Prescott, & Simmer, 
2013).  For this reason, consuming pre-converted long chain PUFAs through diet can be a more 
efficient way to obtain health benefits.  
The Bayley Scales of Infant and Toddler Development – Third Edition (BSID-III) is a 
developmental assessment that can be administered to children between one and 42 months of 
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age. It is comprised of the Cognitive, Language, Motor, Social-Emotional, and Adaptive 
Behavior Scales. Based on the composite scores in the Cognitive, Language, and Motor Scales, 
the assessment identifies signs of developmental delay (Bayley, 2006). The Language Scale 
assesses receptive and expressive language, and the Motor Scale examines both Fine and Gross 
Motor skills (Bayley, 2006).  
 Previous work has associated higher Mental Development Index scores, a BSID-III 
predecessor to the Cognitive Composite, with longer-term consumption of human milk 
(Angelsen et al., 2001). Is has also been found that infants whose mothers supplemented with 
DHA while breastfeeding exhibited a higher Bayley-II Psychomotor Index (predecessor to 
Bayley-III Motor Composite) at 30 months of age (Jensen et al., 2005). Findings from these 
studies indicate the association between the consumption of human milk and cognitive and motor 
benefits during infancy and childhood. These associations also highlight the need for research to 
discover which components in human milk are responsible for these benefits.  
Although human milk has been associated with a multitude of acute and long-term benefits, 
many of the correlations between human milk and superior cognitive functioning may be 
confounded by other factors associated with breastfeeding, such as maternal socioeconomic 
status and IQ (Walfisch, Sermer, Cressman, & Koren, 2013) The practice of consuming milk 
directly from the breast versus pumped milk may also moderate these benefits. Due to the gap in 
knowledge that has resulted from challenges in objectively studying human milk, there is a need 
to relate the fatty acid constituents of human milk to infant health and developmental outcomes 
using a consistent evaluation such as the BSID-III. It is also necessary to consider proportions of 
fatty acids within the milk matrix, as the benefits conferred by single fatty acids may depend on 
the presence or absence of other fatty acids. Infant movement quality, for example, which can be 
 32 
used to assess neurological development in young infants, was found to be sensitive to the 
maternal dietary balance of DHA and ARA. When lactating mothers supplemented with just 
DHA, 61% of the infants exhibited mildly abnormal general movements. Only 31% of infants in 
the control group (meaning the mother was not supplementing with DHA or ARA) and 34% of 
infants whose mothers were supplementing with both DHA and ARA exhibited mildly abnormal 
general movements. (van Goor et al., 2010). In the United States, infant formula generally 
contains ARA to DHA in a 2:1 ratio, since human milk typically contains greater concentration 
of ARA than DHA (Lien et al., 2018).  However, more research is needed to determine if the 
proportions of these and other fatty acids are optimal for infant health and development.  
The objective of the present study was to determine whether the relative amounts of 
unsaturated fatty acids in human milk correlated with the Cognitive, Motor, and Language 
Composite outcomes reported by the BSID-III. It was hypothesized that there would be a 
correlation between greater concentrations of omega-3 EFAs in milk and positive developmental 
outcomes reported by the BSID-III. Elucidating the importance of specific fatty acids and fatty 
acid ratios in human milk represents a public health interest. Knowledge of the optimal 
composition of human milk may facilitate dietary recommendations for breastfeeding mothers 
and aid in the manufacture of more nutritious infant formula products.  
Methods 
Acquisition of human milk and developmental data 
The studies involving human participants were reviewed and approved by Chapman 
University IRB. The patients/participants provided their written informed consent to participate 
in this study (Chapman University REB approval number 1314H044). 
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Mothers were recruited by asking eligible women receiving care at University of 
California, Irvine clinics in Orange County, California (USA). Inclusion criteria for participating 
in the study included: English-speaking, absence of alcohol or drug use during pregnancy, 
absence of endocrine, hepatic, or renal disorders, over 18 years of age, and a singleton 
pregnancy. Women with a disorder related to uterine or cervical function were excluded. Milk 
samples were obtained between 2015 and 2017, and provided between ~9:00 a.m. and 4:30 p.m. 
The samples were stored at -80 oC upon collection. The data collected included the Cognitive, 
Language, and Motor Scales of the BSID-III. Cognitive, Language, and Motor Composite scores 
were obtained at six (n= 60, 61, and 61) and 12 months of age (n= 61, 61, and 61) respectively. 
Data on the proportion of human milk feeding was obtained by interview. Data specifying 
socioeconomic status, sex of the infant, maternal age and education level, parity, ethnicity, and 
cohabitation with the baby’s father was also obtained by interview.  
Fatty acid analysis of human milk 
Fatty acid analysis of human milk aliquots (n=70) was performed at University of 
California, San Diego Lipidomics Core (San Diego, CA, USA). Fatty acids were extracted from  
0.5 µL human milk samples with butanol-methanol extraction (BUME). After solvent removal, 
samples were saponified by adding 250 µL MeOH and 250 µL 1N KOH, incubating for 60 min 
at 37 °C, and neutralizing the pH. Internal standards were added, and fatty acids were extracted
with isooctane. Upon removal of the solvent, fatty acids were derivatized by adding 25 µL 1% 
PFBB and 25 µL 1% DIPEA. Samples were incubated at room temperature for 20 min, solvent 
was removed,  50 µL iso-octane was added, and samples were transferred to MS vial with insert. 
Total esterified and non-esterified fatty acids were quantified using GC-MS (Agilent 5975 
GC/Mass Spectrometer, Mass Hunter, Multiquant software) using an injection volume of 1 µL. 
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The present study reports on 22:6n-3 (DHA), 20:5n-3 (EPA), 20:4n-6 (ARA), 18:3n-3 (ALA), 
18:2n-6 (LA), and 18:1n-9 (OA). The absolute fatty acid concentrations were converted to 
relative percentages for subsequent analysis.  
Statistical Analysis 
Statistical analysis was performed using IBM SPSS® Version 25. Descriptive statistics 
were calculated for sample population characteristics, BSID-III outcomes, and relative 
concentrations of fatty acids in milk. A simple linear regression analysis was used initially to 
model the relation between the relative percentage of the selected fatty acids and the Bayley 
Cognitive, Motor, and Language Composite scores at six and 12 months of age before 
incorporating covariates and modifiers into the regression model. Maternal age, self-reported 
years of education, ethnicity (Latina, non-Latina), infant sex, income to needs ratio (INR) and 
cohabitation with the baby’s father were considered as covariates by correlating with predictor 
and response variables. Maternal age, education, ethnicity, and INR covariates were chosen to be 
incorporated into the regression model.  
The percentage of infant diet comprised of human milk at six months was analyzed as a 
modifier between the relative proportions of fatty acid and the Bayley outcomes. Modifier values 
were incorporated into the regression model, and the p-value of the interaction term between 
modifier and predictor was assessed to determine if proportion of milk consumption in diet 
modified the relation between fatty acids and BSID-III outcomes. For each regression model 
incorporating the modifier, all interaction terms were created with mean-centered variables. A 
significance level of α = 0.05 was used throughout the study. The following sample size 
calculation was performed to detect a 16% (clinically significant) difference in any Bayley 
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subscale score at 80% power in one-tail testing at a 5% level of significance using previously 
reported mean and standard deviation (Badr, 2009).   
n ≈ [(2*(zpower + z1-a)) ÷ ((μ1 – μ2)/δ)]2 
n ≈ [(2*(0.8416 + 1.96)) ÷ (16/15)]2  
n ≈ 35 (per timepoint) 
Equation 3-1. Sample size calculation for determination of clinically significant differences in 
Bayley subscale score means. 
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Results 
Table 3-1. Maternal and demographic information and categorical level of education for the 70 
mother-child pairs in the present study. INR is reported as percent above or below the poverty 
line. 
Infant and Maternal 
Demographic  




















Birth order (%) Some college, 
but no degree 
9 (12.9%) 
First born 36 (51.4%) 
Second born 23 (32.9%) 
Third born 8 (11.4 %) 
Fourth born 2 (2.9%) 










Cohabiting with baby’s 




Table 3-2. Descriptive statistics for the Bayley Cognitive, Motor, and Language Composite 
scores at six and 12 months of age.    
Scale Time 
(month) N 
Mean Minimum Maximum SD 
Cognitive 
Composite 
6 60 102.83 75 120 10.27 
Cognitive 
Composite 
12 61 105.66 85 135 11.20 
Motor 
Composite 
6 61 93.61 65 115 10.69 
Motor 
Composite 
12 61  96.40 73 121 10.00 
Language 
Composite 
6 61 97.62 77 115 9.02 
Language 
Composite 
12 61 99.66 77 132 10.00 
Table 3-3. Descriptive statistics for the select fatty acid composition of human milk (n=70) 
reported as relative percentages. 
Fatty Acid Mean Minimum Maximum SD 
DHA 0.729 0.2 2 0.423 
EPA 0.089 0 0.3 0.075 
ARA 0.883 0.5 2 0.279 
ALA 1.414 0.5 3.7 0.517 
LA 14.569 6.9 28.4 3.257 
OA 35.830 25.1 47.9 4.185 
ARA/LA 0.063 0.024 0.17 0.025 
DHA+EPA 0.817 0.2 2.3 0.482 
(DHA+EPA)/ALA 0.676 0.125 3 0.542 
(Master’s, 
Doctorate) 
Income to needs ratio (n, 
mean ± SD, median) 68, 474.72 ± 
489.35, 364 
Certificate 3 (4.3%) 
Average years of 
education, (n, mean ± 
SD) 
68, 15.67 ± 
3.28 
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Table 3-4. Linear regression analysis for fatty acids and BSID-III scores. Simple linear 
regression tables comparing fatty acids and (A) Bayley Cognitive Composite, (B) Motor 
Composite, and (C) Language Composite scores at six and 12 months of age. Statistically 
significant correlations (p <0.05) are denoted with an asterisk (*). B represents the 
unstandardized coefficient while β represents the standardized coefficient.  
A) 6 Months 12 Months 
 R2  B β p  R2  B β p 
DHA 0.004 3.498 0.144 0.274 -0.006 2.913 0.103 0.428 
EPA 0.030 30.769 0.215 0.099 -0.016 4.926 0.032 0.809 
ARA 0.005 -5.246 -0.147 0.263 0.057 -10.498 -0.269 0.036*
ALA -0.007 2.246 0.099 0.453 -0.016 -0.606 -0.025 0.850
LA -0.014 0.198 0.054 0.682 -0.015 -0.179 -0.045 0.731
OA 0.031 -0.552 -0.218 0.094 -0.017 0.054 0.020 0.880 
ARA/LA -0.015 25.959 0.051 0.701 0.036 -101.629 -0.228 0.077
DHA+EPA 0.009 3.443 0.160 0.223 -0.008 2.371 0.096 0.463 
(DHA+EPA)/ALA 0.010 3.184 0.163 0.214 0.005 3.223 0.146 0.260 
B) 6 Months 12 Months 
 R2  B β p  R2  B β p 
DHA -0.017 -0.162 -0.005 0.968 -0.006 -1.586 -0.063 0.629
EPA -0.017 -1.152 -0.006 0.961 -0.003 -16.388 -0.118 0.366
ARA 0.044 -11.23 -0.246 0.056 0.018 -6.455 -0.185 0.153
ALA -0.015 -1.395 -0.048 0.712 0 -2.798 -0.128 0.327
LA -0.012 -0.330 -0.070 0.590 -0.007 -0.345 -0.097 0.457
OA -0.016 0.121 0.037 0.776 -0.014 -0.121 -0.050 0.703
ARA/LA -0.015 29.135 0.044 0.734 -0.012 -27.34 -0.069 0.598
DHA+EPA -0.017 -0.154 -0.006 0.966 -0.011 -1.636 -0.074 0.571
(DHA+EPA)/
ALA 
-0.001 3.145 0.126 0.333 -0.005 2.134 0.109 0.404
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C) 6 Months 12 Months 
 R2  B β p  R2  B β p 
DHA 0.002 3.456 0.136 0.297 0.01 -4.063 -0.161 0.214
EPA 0.041 35.359 0.238 0.065 -0.016 -16.388 -0.118 0.366
ARA 0.034 -8.392 -0.224 0.083 0.050 -8.940 -0.256 0.046*
ALA 0.021 4.601 0.194 0.135 -0.015 -2.798 -0.128 0.327
LA -0.007 0.387 0.100 0.441 -0.015 0.172 0.048 0.712
OA -0.008 0.253 0.095 0.466 -0.008 0.235 0.096 0.460
ARA/LA -0.011 -39.464 -0.073 0.574 -0.004 44.851 0.113 0.387
DHA+EPA 0.008 3.517 0.156 0.229 0.002 -3.034 -0.137 0.292
(DHA+EPA)/
ALA 
-0.015 0.858 0.042 0.748 -0.009 -1.786 -0.091 0.486
Table 3-5. Regression analysis of ARA and Bayley Cognitive Composite and Language 
Composite scores at 12 months of age after adjusting for the following covariates: Self-reported 
years of maternal education, maternal age, INR, ethnicity  
Cognitive 12 Months Language 12 Months 
B β p B β p 
ARA -10.282 -0.266 0.048 -8.145 -0.235 0.083 
Table 3-6. Linear regression model of ARA in relation to Bayley Cognitive Composite scores at 
12 months of age after incorporating the following modifier: Percentage of infant diet comprised 
of human milk at six months. 
B β  p 
(ARA)*(% Milk) -0.073 -0.088 0.571 
ARA -9.556 -0.258 0.11 
% Milk 0.014 0.054 0.697 
The participants in the present study consisted of 70 mothers recruited in Orange County, 
CA (USA). Demographic information was obtained (Table 3-1), and descriptive statistics were 
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calculated for BSID-III scores of the infants (Table 3-2) and for the fatty acid composition of 
human milk from participants (Table 3-3). At six months, the relation between the individual 
fatty acids, fatty acid ratios, and BSID-III Cognitive Motor, and Language Composite scores was 
not statistically significant (Table 3-4A-C). However, the relative percentage of ARA was 
significantly correlated (p<0.05) with Bayley Cognitive Composite scores at 12 months of age 
(Table 3-4A). After including the following covariates in the regression model, this relation 
remained statistically significant: maternal age, education, ethnicity, and INR (Table 3-5).  
Prior to accounting for covariates, ARA was significantly correlated to Bayley Language 
Composite scores at 12 months of age (Table 3-4C). However, after including covariates in the 
regression model, this relation became a non-significant trend (p>0.05<0.10) (Table 3-4C). The 
following non-significant trends were also observed in the simple linear regression models: the 
relation between ARA and Bayley Cognitive Composite scores at six months, OA and Bayley 
Cognitive Composite scores at six months, ARA/LA and Bayley Cognitive Composite scores at 
12 months, EPA and Bayley Language Composite scores at six months, and ARA and Bayley 
Language Composite scores at six months.  
Potential modifiers based on the exclusivity of human milk consumption were also 
considered (Table 3-6). At six months of age, 63 participants out of 70 reported the percentage of 
infant diet that was comprised of their human milk (data not shown). It was found, however, that 
the percent of diet from human milk at six months did not moderate the association between 
ARA and Bayley Cognitive Composite scores (Table 3-6) (all p values > 0.05).  
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Discussion
The relative amount of ALA, ARA, and EPA in milk of participants in the present study 
(Table 3-3) is similar to values reported in literature (Barreiro et al., 2018). An analysis of the 
fatty acids in milk from women in Northwest Spain at was similar to milk in the rest of Europe 
and the world at the same or similar points of lactation (Barreiro et al., 2018). However, 
several fatty acids quantified for the present study at two weeks of lactation differed from the 
values from one month of lactation reported by (Barreiro et al., 2018). In the present study, 
milk from participants had a greater mean concentration of DHA (0.73%) than participants in 
previously reported studies (0.36%) (Barreiro et al., 2018). Additionally, milk from 
participants in the present study contained a mean concentration of ARA almost double that of 
a previously reported study (0.883% and 0.49% respectively) (Barreiro et al., 2018).   
Table 3-1. Average fatty acid content of human milk at one month postpartum in mothers from 
Northwestern Spain (Barreiro et al., 2018) compared to the fatty acid content of human milk in 
the present study.  
Fatty Acid Average Relative 
Percentage (Barreiro et 
al., 2018) (n=157) 
Average Relative 
Percentage in the 
Present Study (n=70) 
DHA 0.36 ± 0.17 0.729 ± 0.423 
EPA 0.11 ± 0.05 0.089 ± 0.075 
ARA 0.49 ± 0.11 0.883 ± 0.279 
ALA 0.48 ± 0.12 1.414 ± 0.517 
LA 14.12 ± 3.16 14.569 ± 3.257 
OA 34.3 ± 2.61 35.83± 4.185 
 Human milk from two weeks and one month postpartum are comparable for research 
purposes, as after two weeks, milk is considered generally mature (Ballard & Morrow, 2013). 
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Thirty of the 70 participants in the study were Hispanic/Latina (Table 3-1A). However, it is 
unlikely that elevated DHA composition in the milk obtained from participants of the present 
study is related to ethnicity. In fact, the fatty acid concentration of DHA in the milk of women in 
other areas of the world, such as Latin America, was found to be similar to fatty acid profiles 
from Europe (Barreiro et al., 2018). Thus, the increased concentration of DHA in the milk of 
women in the present study is likely diet-related. However, maternal dietary records were not 
obtained to confirm this.  
ARA was inversely related to Bayley Cognitive Composite scores at 12, but not six months 
of age (Table 3-4;Table 3-6). The importance of this observation extends beyond infancy, since 
Bayley Cognitive Composite scores in infancy are an indicator of cognitive development in 
childhood (Berk, 2013). In the present study, the composition of human milk at two weeks 
postpartum predicted BSID-III Cognitive development at 12 months. The lack of statistically 
significant findings at six months of age may be attributed to greater accuracy of the health and 
behavioral assessments at 12 months of age, when infants are more emotive and expressive than 
at six months of age. In fact, one critique of the BSID-III is that the reliability is lacking for 
younger children (aged zero to six months). However, reliability is an inherent challenge in any 
instrument intended for use in populations with high developmental variation, such as young, 
rapidly developing infants.  
In the present study, DHA was not significantly correlated with developmental outcomes at 
six or 12 months of age. It was previously found that infants whose mothers supplemented with 
DHA during breastfeeding exhibited a higher Bayley-II Psychomotor Index (predecessor to 
BSID-III Motor Composite) at 30 months of age, but not at any 12 months of age (Jensen et al., 
2005). However, the advantage of a higher Psychomotor Index was unclear, since the mean of all 
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groups was above the expected mean. The delayed effect of psychomotor development may have 
been observed because DHA early in life is necessary for developmental domains that are 
manifested later in life, or because DHA confers psychomotor benefits that are not detected due 
to the lack of sensitive tests early in life (Jensen et al., 2005). Therefore, it is possible that DHA 
or another fatty acid in the present study may have been significantly correlated to Bayley Motor 
scores if results past 12 months were recorded.  
The amount of variation in BSID-III scores explained by fatty acids and fatty acid ratios in 
statistically significant regression models is smaller than R2 = 0.1, and can thus be classified as 
“small,” (Murphy & Myors, 2004) (Table 3-4;Table 3-6). However, a single fatty acid or fatty 
acid ratio explaining even 5-10% of the variation in complex development outcomes influenced 
by other factors such as genetics could have major public health implications, including 
personalized nutritional recommendations for lactating mothers, and the development of milk 
fortifiers and infant formulas. Although mothers cannot change genetic factors that may 
influence the composition of their milk, nutrition is a more accessible and easily-implemented 
strategy to optimize the nutritional benefits of human milk consumed by infants.   
 In the present study, ARA was inversely correlated with Bayley Cognitive Composite 
scores at 12 months after covariate analysis. Relative percentages of other essential fatty acids to 
which developmental benefits have previously been attributed, such as DHA, did not correlate 
with BSID-III outcomes. However, this may be due to the specific population in the present 
study. The average relative percentage of DHA reported in the present study was 0.729% 
compared to 0.36% reported in a previous study at a similar timepoint (Table 3-3). The majority 
of the infants in the present study may therefore have consumed DHA in excess of levels 
necessary to confer health and developmental benefits. Hence, variations in the levels of DHA in 
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the human milk studied may not have predicted developmental outcomes due to the absence of 
samples containing little to no DHA. Future work studying human milk with more of a range of 
DHA concentrations and the ratio of DHA/ARA may provide more insight. It should also be 
noted that the sample size calculation (Equation 1) does not include the incorporation of 
covariates. Given the rigorous incorporation of four covariates in the present study, a larger study 
group may yield statistically significant results in Bayley Language Composite scores after 
covariate analysis. 
The average relative percentage of ARA in the milk of participants in the present study was 
roughly twice as high as previously reported (Table 3-7). ARA has been associated with 
cognitive development in infants, and is typically added to infant formula in a 2:1 ratio with 
DHA in the United States (Lien et al., 2018). In the present study, the ratio of ARA to DHA was 
1.1 to 1  (Table 3-3). Interestingly, previous work reported a reduced benefit in some cognitive 
measures when infants consumed formula with a higher DHA to ARA ratio (1.5:1) compared to 
intermediate doses of DHA (1:1 and 1:1.5 DHA to ARA). This effect was observed at 60 and 72 
months using the Peabody Picture Vocabulary Test, 3rd edition and the Full Scale IQ derived 
from the Wechsler Preschool and Primary Scale of Intelligence, 3rd edition respectively 
(Colombo, Shaddy, Kerling, Gustafson, & Carlson, 2017). Colombo et al. (2017) noted that 
previous research of LCPUFA distribution in the brain tissue of baboons displayed a similar 
trend. Baboons that were fed the highest dose of DHA:ARA (also a 1.5:1 DHA:ARA ratio) in 
formula indicated a reduction in the tissue concentration of ARA in all areas of the brain. By 
studying the fatty acid composition of red blood cells in the infants, it was determined that the 
DHA composition of red blood cells at 4 and 12 months of age plateaued between infants 




dose. Increased concentrations of specific fatty acids in human milk and formula may therefore 
lead to lower accretion of other fatty acids in areas of the brain, resulting in the reduction in 
cognitive benefits. Additionally, similar to the findings of the brain tissues in baboons, the 
concentration of ARA in red blood cells actually decreased in response to the highest dose of 
DHA compared to the intermediate doses (Colombo et al., 2017).  
It was previously hypothesized that a high ratio of omega-3 to omega-6 fatty acids led to 
the inhibition of Δ6-desaturase, impeding the conversion of LA to ARA, making ARA 
unavailable for growth (Hadley, Ryan, Forsyth, Gautier, & Salem, 2016). In the present study, 
however, the concentration of both DHA and ARA were higher than previously found, so this 
may not be a plausible explanation for the inverse correlation between ALA and infant 
development. Additionally, due to low conversion rate of LA to ARA, the levels of these fatty 
acids in human milk are primarily reflective of the preformed DHA and ARA consumed in diet. 
Thus, the mechanistic relation between fatty acids, such as ARA, and developmental outcomes is 
exceedingly complex, and should consider relative percentages of specific fatty acids interacting 
in the complex milk matrix.   
Adequate concentrations of PUFAs in the brain early in life are important, because fatty 
acids influence processes such as membrane dynamics and cell signaling. As the infant’s brain 
grows, levels of ARA and DHA increase during the last three months of pregnancy and during 
the first five years of life. Importantly, dietary intake of fatty acids early in life affects fatty acid 
accretion in the brain. In contrast to the cerebral cortex, which is of interest for higher-level brain 
functioning, the cerebellum is important for movement and balance. The percentage of DHA in 
white matter in the cerebellum has been found to be lower in formula fed infants than in infants 
fed human milk. However, no differences in cerebellar white matter content were observed for 
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ARA (Lien et al., 2018). EFA are thought to promote development through a variety of 
mechanisms. While DHA is understood to control signaling membranes in the brain and nervous 
system, ARA is important for brain growth during gestation and early in infancy, where it plays a 
role in cell signaling and division. ARA mediates various functions in the brain, including 
neuronal firing, signaling, and long-term potentiation. Among other functions, ARA also 
maintains membrane order and hippocampal plasticity (Hadley et al., 2016).  
Understanding accretion of fatty acid levels in areas of the brain associated with specific 
functions may mechanistically implicate the role of specific fatty acids in different development 
functions. Moreover, quantifying the proportion of fatty acids necessary for optimal development 
may lead to greater understanding of structure-function relationships. This knowledge may also 
facilitate application of this knowledge to nutritional recommendations and development of milk 
fortifier and infant formula products. The present study represents novel research, because 
specific percentages of ARA present in human milk, instead of infant formula, have now been 
quantified and correlated to BSID-III Cognitive, Motor, and Language scores. BSID-III 
outcomes can be extrapolated more broadly to cognitive, motor, and language ability in infants. 
Objectively quantifying and relating fatty acids in human milk to development is necessary to 
develop nutritional guidelines for breastfeeding mothers and to inform the development of infant 
nutrition products.  Quantitative knowledge implicating specific percentages of product to 
precursor fatty acids in relation to development is also a segue to future work considering the 
FADS gene and maternal and infant genotype. 
 47 
Limitations
The present study has several limitations. The gold standard of milk collection involves 
sampling all milk expressed over 24 hours (Ballard & Morrow, 2013). This was not the practice 
for the present study. In addition to limitations related to the collection of milk aliquots, the 
scope of the present study also presents a limitation. Maternal and infant genotyping was not 
performed, so genotype could not be incorporated into the regression models as a modifier. It is 
well known that there is inter-individual variability in the metabolism of fatty acids. The 
FADS-1 and FADS-2 enzymes encoded by the FADS gene modulate the synthesis of ARA and 
DHA from LA and ALA respectively. Polymorphisms in the FADS-1 and FADS-2 genes encode 
the enzymes that alter the production and thus concentration of LC-PUFAs (Lattka et al., 2009). 
In future work, controlling for how efficiently lactating mothers can synthesize LC-PUFAs that 
are present in milk and how efficiently infants can synthesize LC-PUFAs from the precursors in 
the milk they consume will provide a more objective measure of the developmental outcomes 
associated with specific essential fatty acids. An additional limitation of the present study is that 
maternal diet and supplementation records were not obtained. For a more comprehensive 
analysis, future work could include maternal diet and supplementation records in addition to 
infant and maternal genotyping.  
Conclusion 
In conclusion, the relative percentage of ARA in human milk may influence language and 
cognitive ability in infants. There was an inverse relation between ARA and Bayley Cognitive 
Composite scores at 12 months of age, and an inverse relation (non-significant trend) between 
ARA and Language Composite scores 12 months of age. Exclusivity of human milk feeding at 
six months did not modify BSID-III outcomes in the study population. Future work with a larger 
sample population may yield additional statistically significant results after accounting for 
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covariates. Furthermore, future work accounting for other known modifiers, such as maternal 
and infant FADS genotype, may provide a more thorough understanding of the relation between 
essential fatty acids and development. The statistically significant correlations and non-
significant trends observed in present study prompt further consideration of optimal proportions 
of fatty acids in human milk and infant formula to inform nutritional recommendations for 
breastfeeding mothers and product development initiatives.  
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4. Isolation of EVs from Human Milk
Introduction 
It is well-known that consumption of human milk is associated with enhanced infant 
health outcomes in comparison to consumption of infant formula. However, it is not fully known 
which components of human milk may be responsible for supporting optimal health and 
development of newborns. Increasing research suggests that EVs from human milk have 
physiologic function that may impact acute and chronic health outcomes. Human milk EVs 
promote epithelial cell growth in the intestine (Hock et al., 2017a) and were found to protect 
intestinal epithelial cells from oxidative stress (C. Martin, Patel, Williams, Arora, & Sims, 2018). 
Additionally, human milk EVs have been implicated in the immune modulating function of 
human milk, and may play a role in the development of the neonatal immune system (Zonneveld 
et al., 2014). These effects may be attributed to the protein, lipid, or microRNA cargo of human 
milk EVs (Zonneveld et al., 2014). A reliable method for consistent isolation of EVs from human 
milk is needed to determine the functional components of EVs to which enhanced infant health 
outcomes can be attributed. 
Although UC is the most commonly used method to isolate EVs from biospecimens (T 
Skotland et al., 2017), the feasibility of this method for human milk research is limited. As a 
precious biofluid for feeding newborns, acquiring the large volume of human milk needed for 
EV isolation using UC is not always feasible. Unfortunately, no method of EV isolation has been 
authenticated for use with a low volume of human milk (≤2 ml); prior studies have isolated 
human milk EVs from a starting volume of 9 mL (Vaswani, Qin Koh, Almughlliq, Peiris, & 
Mitchell, 2017). As a result, the limitations in conducting research in this area have created a 
knowledge gap. Additionally, authentication of an EV isolation method from low volumes of 
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human milk will facilitate research on EVs throughout milk production periods, the course of 
lactation, over time-of-day variation, and perhaps most importantly in low volume producers, 
which are not adequately studied. 
This limitation has several potential negative consequences. First, analysis of only large 
volumes may limit research to use of pooled human milk. This measure would result in a greater 
understanding of average milk composition but not of interindividual variability. Second, 
analyses may be limited solely to time of lactation when higher volumes of milk are produced. 
This may then result in a disparate understanding of mature milk relative to early and transitional 
milks. Finally, research may be limited to studies of mothers with high volume of milk 
expression instead of low volume producers. Therefore, a strong need exists for a method of 
isolate EVs from a low volume of human milk. 
A novel method for the isolation of EVs requires verification procedures. The 
International Society for Extracellular Vesicles (ISEV) released MISEV guidelines in 2018 
(Théry, Witwer, & Aikawa, 2018) detailing the minimum criteria for confirming isolation of 
EVs. MISEV guidelines recommend that each EV preparation be (i) defined quantitatively by the 
source of EVs, (ii) characterized to determine the abundance of EVs by total particle number or 
protein/lipid content, (iii) tested for components associated with EV subtypes or EVs generically, 
and (iv) tested for the presence of non-vesicular co-isolated components. This paper describes a 
precipitation-based method for the isolation of EVs from human milk. The subsequent 
characterization of EVs suggest successful isolation in compliance with the MISEV guidelines. 
EVs isolated using the present method are therefore appropriate for downstream characterization 




Mature milk (>6 months after initiation of lactation) was pooled and pasteurized from donors to 
develop the EV isolation method (Prolacta Bioscience, City of Industry CA). Twelve volunteers 
also provided samples of expressed milk between 2 and 4 weeks postpartum which were 
immediately frozen at −80°C. Ethics approval was obtained from the Chapman University 
Institutional Review Board. The EV isolation method (Figure 4-1) outlined herein is adapted 
from the instructions for a commercial precipitation reagent (SBI, 2018b) and a previously 
published protocol (X. Wang, 2017). 
Figure 4-1. Workflow schematic for EV isolation using a precipitation-based isolation method. 
Thaw human milk 
aliquots
Centrifuge at 2,000 x 
g, 10 min, remove fat 
layer. Ideally, defat 
before freezing.
Centrifuge de-fatted 
milk at 12,000 x g 
for 30 min, discard 
debris at bottom of 
tube
Filter milk through 
0.45 μm cellulose 
syringe filter 
Add ExoQuick-TC™ 
reagent (5:1 milk: 
ExoQuick TC™) and 





(5000 x g for 30 
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1. Thaw frozen human milk at 4°C. Once thawed, vortex milk for ~3 s.
2. If milk was not aliquoted into microcentrifuge tubes prior to freezing, aliquot 1.5–2 mL (or 
desired volume) human milk into microcentrifuge tubes.
3. Centrifuge at 2,000 × g for 10 min to separate and remove the fat layer with a metal spatula. 
Discard the fat layer and transfer milk to a new tube. Removing the fat layer also removes 
milk fat globules (Le et al., 2009).
4. Centrifuge the defatted milk at 12,000 × g for 30 min to remove cell debris. Transfer milk 
supernatant and/or discard pellet.
5. Filter milk supernatant through a 0.45 μm cellulose syringe filter into a new microcentrifuge 
tube to further eliminate cells and cellular debris.
EV Isolation 
6. Using a 5:1 ratio of milk supernatant: ExoQuick-TC™ reagent (System Biosciences, Palo
Alto CA), add reagent to the filtered milk and gently invert until mixed.
7. Incubate at 4°C overnight or for at least 12 h.
8. After incubation, centrifuge at 5,000 × g for 30 min (beige pellet will appear at the bottom of
the tube).
9. Discard supernatant, and resuspend EV pellet in 100–600 μL PBS (pH 7.4).
10. Depending on downstream application, use resuspended EVs stored at 4°C within 3 days or
freeze immediately at −80°C.
Scanning Electron Microscopy 
Zeiss Gemini Sigma 300 scanning electron microscope (SEM) was used to visualize EVs 
isolated from milk expressed at 2 weeks postpartum (n = 1 volunteer). EVs were visualized 1 day 
EV Isolation Method
Thawing, Defatting, and Removal of Cell Debris
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after they were isolated, resuspended, and stored at 4°C. The original EV resuspension in PBS 
(500 μL) was further diluted in PBS (1:1,000). SEM slides were prepared with 2 μL of diluted 
EVs. Argon gas sputter coating of EVs with 3 nm gold-palladium alloy was performed to prevent 
sample destruction. 
Nanoparticle Tracking Analysis 
Nanoparticle Tracking Analysis (NTA; Nanosight NS01) was used to determine the 
concentration and size of EVs isolated from the pooled milk sample. A sample of EVs originally 
resuspended in PBS (500 μL) and frozen at −80°C was thawed on ice and further diluted in PBS 
(1:75) prior to injection. Detection threshold was set to four, and three runs each of 30 s in 
duration were completed and analyzed using NTA 3.1 software. Total yield (EV particles/mL 
milk) was calculated based on dilution factors and a starting volume of 1.5 mL milk. 
Dynamic Light Scattering 
The diameter of EVs isolated from the pooled milk sample was measured with a Mobius 
Dynamic Light Scattering (DLS) instrument (Wyatt Technology) using DLS Firmware Version 
1.2.0.0. Laser wavelength was set to 532 nm, and a detector angle of 163.5° was used. DLS 
acquisition time was set to 5 s and a number acquisition of three was used to perform three 
technical replications on EVs stored at 4°C over the course of 10 days. 
 54 
The Exocheck™ Antibody Array (System Biosciences, Palo Alto CA) was used according to the 
manufacturer's instructions (SBI, 2018a) to determine the presence or absence of common EV 
proteins (CD63, EpCAM, Annexin5, TSG101, Flotilin1, ICAM, ALIX, CD81) in EVs isolated 
from milk expressed at 4 weeks postpartum (n = 1 volunteer). Resuspended EVs were thawed on 
ice prior to antibody array analysis. 
Determination of Total Fatty Acid Concentration 
The EVs from which fatty acids were analyzed were isolated using 2 mL aliquots of pooled milk, 
and with variations in EV isolation steps. A 5:1 and 10:1 ratio of milk supernatant: ExoQuick-
TC™ reagent was used with or without (0.45 μm cellulose) filtration or purification using 
ExoQuick-TC™ ULTRA purification columns according to the manufacturer's instructions 
(System Biosciences, Palo Alto, CA). Prior to fatty acid analysis, EVs were isolated from the 
pooled milk sample, resuspended in PBS (500 μL), frozen at −80°C, and thawed on ice. Fatty 
acid analysis was performed by Creative Biostructure (Shirley, NY USA). 
The total fatty acid concentration of EVs was determined by colorimetric analysis in triplicate 
(n = 1 per isolation variation). Standards were prepared with palmitic acid (1 nmol/μL). Samples 
were diluted and homogenized. Standard dilution (50 μL) or sample (0.5–25 μL) were added to 
each sample well. The final volume was adjusted to 50 μL with assay buffer. An acyl-coenzyme 
A synthetase reagent (2 μL) was added to each reaction well, mixed, and incubated (20 min, 
37°C). Samples were then incubated (30 min, 37°C) in the dark with reaction mix (2 μL) 
containing assay buffer (44 μL), fatty acid probe (2 μL), enzyme mix (2 μL), and enhancer (2 
μL). Finally, optical density was measured on a microplate reader at 562 nm. 
Exocheck Antibody Array
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A Qubit™ 4 Fluorometer was used to measure the protein concentration in human milk EVs 
isolated from milk expressed at 2 weeks postpartum (n = 10 volunteers). Resuspended EVs were 
thawed on ice prior to protein quantification. The instrument was calibrated with protein 
standards according to the manufacturer's instructions (ThermoFisher, 2018). EV samples 
originally resuspended in 600 μL PBS were thawed on ice and diluted in PBS (1:20). Lysis 
buffer (10 μL) was added and samples were vortexed (Protease Inhibitor Cocktail, RIPA buffer, 
Thermo Fisher Scientific, Waltham MA). Protein concentration was measured in duplicate after 
incubating (15 min, room temperature) the lysate (1 μL) with working reagent (199 μL). Protein 
quantification of EVs was calculated based on dilution factors and a starting volume of 1.5 mL 
milk. 
Results 
SEM (Figure 4-2), NTA (Figure 4-3) DLS (Figure 4-4), and an antibody array (Figure 4-5) were 
used to image, quantify, measure the average diameter, and identify protein markers 
characteristic of EVs. The image obtained by SEM revealed the size of nanovesicles in the 
expected range for EVs, approximately 50–350 nm (Figure 4-2). Results from analysis by NTA 
revealed that the isolation method yielded 8.9 × 109 (± 1.1 × 109) particles/mL of human milk. 
The mean and mode diameter of EVs were 179.3 and 150.3 nm, respectively (Figure 4-3). No 
standard deviation is reported for the mean since a trimodal distribution of EV populations was 
observed. Results from DLS (Figure 4-4) showed that the average diameter of EVs 1 day after 
isolation was 213.6, and 249.7 nm 10 days after isolation. Error bars for individual days were 
excluded because individual standard deviations for technical replicates were <5% of the mean. 
Antibody array (Figure 4-5) indicated that the sample was positive for the following known EV 
Protein Quantification
 56 
markers: cluster of differentiation 81 (CD81), ALG-2-interacting Protein X (ALIX), intracellular 
adhesion molecule (ICAM), tumor susceptibility gene 101 (TSG101), and Annexin5, and 
negative for cluster of differentiation 63 (CD63), epithelial cell adhesion molecule (EpCAM), 
and flotilin1. 
Figure 4-1. Image of EVs obtained by SEM from participant (n = 1), Electron high tension = 
5.00 kV, working distance = 20.9 mm, detector = secondary electron, magnification = 8.70 K X, 




Figure 4-3. Diameter and concentration of human milk EVs from pooled human donor milk 
measured by NTA. Technical replicates were performed in triplicate (solid line = trial 1; dashed 
line = trial 2; dotted line = trial 3) (A) and the average of the three runs was calculated (B). The 
above graphs are plotted from the 10th−90th percentile of EV sizes (22.5–312.5 nm) to exclude 



































































Figure 4-2. Average diameter of EVs from pooled human donor milk measured for 10 
consecutive days after isolation and storage at 4°C. Error bars were excluded because individual 
standard deviations were <5% of the mean. Pooled SD = 33.45. 
Figure 4-3. Antibody array of human milk EVs from participant (n = 1). PC represents the 
positive control, and GM130 is a cellular contamination marker. CD 63 = cluster of 
differentiation 63, EpCAM = epithelial cell adhesion molecule, TSG101 = tumor susceptibility 
gene 101, ICAM = intracellular adhesion molecule, ALIX = ALG-2-interacting Protein X, CD81 











































After verification of isolation, human milk EVs were characterized by quantifying total fatty 
acids (Figure 4-6) and protein concentration (Table 4-1). The average total fatty acid 
concentration of EVs isolated with the recommended method (5:1, filter, no column purification) 























Figure 4-4. Antibody array of human milk EVs from participant (n = 1). PC represents the 
positive control, and GM130 is a cellular contamination marker. CD 63 = cluster of 
differentiation 63, EpCAM = epithelial cell adhesion molecule, TSG101 = tumor susceptibility 
gene 101, ICAM = intracellular adhesion molecule, ALIX = ALG-2-interacting Protein X, CD81 
= cluster of differentiation 81. 
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Equation 4-1. Calculation of average concentration of fatty acids present in human milk EVs. 
Total fatty acids were measured. 
 
Table 4-1. Protein concentration of EVs isolated from human milk of 10 different participants 
measured in duplicate.  

















The method of EV isolation from human milk described herein meets the MISEV criteria 
(Théry et al., 2018) for verifying the presence of EVs. EVs isolated with the proposed method 
were (i) quantified in relation to the source of human milk, (ii) characterized to determine the 
abundance of EVs by total particle number and lipid & protein content, (iii) tested for the 
presence of markers associated with EVs, and (iv) tested for the presence of non-vesicular co-




reagent (SBI, 2018b) and previous literature (X. Wang, 2017) was shown to be suitable to 
adequately characterize EVs isolated from human milk and for downstream applications. 
There is consistency between the average EV diameter measured by SEM, NTA, and 
DLS (Figures 4-2, 4-3, and 4-4). Unlike NTA which generates size distribution data, DLS 
measures the average particle diameter. Measurement by DLS then may be skewed by low 
concentrations of outliers or clustering of particles (Van der Pol et al., 2010). Therefore, the 
~15% difference in diameter between SEM, NTA, and DLS measurements could be due to 
overestimation of diameter by DLS. The recommended method presented herein yielded 8.9 × 
109 (± 1.1 × 109) EV particles/mL of human milk. Another group isolated human milk EVs and 
reported a yield of 8.0 × 1010 particles/ml of milk using a UC based method (Vaswani et al., 
2017). The difference in yield could be attributed to the fact that banked, pasteurized milk was 
used in the present method. Additionally, EVs were frozen and thawed prior to quantification 
without defatting before initial freezing, which has shown the decreased recovery of EVs 
(Zonneveld et al., 2014). 
In the MISEV guidelines, it is recommended that operational terminology for 
extracellular vesicles based on factors such as size be used. EVs <200 nm in diameter would be 
considered “small,” and EVs >200 nm considered medium or large (Théry et al., 2018). Results 
from NTA indicated that the greatest concentration of particles is around 153 nm (Figure 4-3), 
meaning the EV population in highest abundance would be classified as small. The 10th−90th 
percentile of particle size were graphed (Figure 4-3) as particles outside this range were likely 




Because storage conditions may affect EV characterization, MISEV guidelines indicate 
the importance of describing storage conditions such as storage container, temperature, buffer, 
freeze-thaw cycles of biofluid and EVs, etc. (Théry et al., 2018). It was previously found even 
that storage of EVs for 2 h at 4°C decreased the viability of the exosome population, but the 
change in size was not measured (Zonneveld et al., 2014). The timecourse experiment (Figure 4-
4) represents storage-induced changes in diameter starting from freshly isolated EVs measured 
over the course of 10 days. The average diameter of EVs measured by DLS increased over time 
after isolation and storage. This may indicate swelling and enlargement of EVs, or aggregation of 
particles. Therefore, when performing studies to determine the relation between structure and 
function, it may be advantageous to use EVs immediately after isolation. 
For protein-based verification of EV isolation, MISEV guidelines stipulate that at least 
one type of protein in two broad categories should be positively identified and the absence of one 
negative marker indicated. These categories include transmembrane or GPI-anchored proteins, 
such as the tetraspanins CD63 and CD81, and EV-recovered cytosolic proteins such as ALIX 
and flotillins-1 and 2. To verify the absence of non-EV isolated co-structures, markers such as 
albumin can be used (Théry et al., 2018). The antibody array (Figure 4-5) verified that human 
milk EVs isolated were positive for proteins in the tetraspanin and EV-recovered cytosolic 
proteins category, and also negative for cellular contamination marker. 
The amount of exosomal protein has been used as a means of EV quantification (Kim, 
Tan, & Lubman, 2015). Considering that the average protein concentration measured in EVs was 
5.08 mg/dL, EV protein comprises ~0.42% of total protein from mature human milk, assuming 
the protein concentration of mature human milk is ~1,200 mg/dL (Ballard & Morrow, 2013). 




not be a consistent and reliable method of quantification due to the presence of co-isolated 
molecules. Therefore, we reported the total fatty acid concentration of human milk EVs (Figure 
4-6). Based on the assumption that fat content of human milk is primarily in the form of 
triglyceride, we estimated that EV fatty acids are ~0.8% of total fatty acids in mature human 
milk (Ballard & Morrow, 2013). 
We compared fatty acid quantification among EVs isolated from human milk with 
different volumes of reagent, use of size exclusion filter, and with or without column affinity 
purification. We suggest a supernatant-to-precipitation reagent ratio of 5:1 for optimal yield of 
EVs to quantify fatty acids. We also suggest filtration of milk by size exclusion after defatting to 
remove non-EV artifacts such as casein and cellular debris. However, it is unclear whether 
column affinity purification after EV isolation performs similarly to size exclusion filtration of 
milk supernatant prior to EV isolation. Although fatty acid quantification was similar after each 
method, it is unknown if filtration and purification result in differences in the EV populations 
isolated. 
The present method of isolating EVs from human milk fulfills the MISEV criteria by 
characterizing the EVs with quantitative and qualitative methods, confirming the presence of 
characteristic EV markers, and confirming (Figure 4-5) the absence of non-EV components. The 
application of this isolation method extends beyond the applications detailed in our manuscript. 
The ability to successfully isolate EVs from small volumes of human milk can be applied to 







EVs were successfully isolated from human milk using a precipitation reagent. The method 
yielded 8.9 × 109 ± 1.1 × 109 EV particles/mL of human milk. Protein and fatty acid 
concentration of EVs in human milk were determined and the percentage of fatty acids and 
protein in EVs relative to the whole milk were ~0.8% and ~0.42%, respectively. The method 
presented is consistent and reliable for isolating, quantifying, and characterizing human milk 
EVs for research and clinical purposes and in continuing to understand the human milk food 
matrix. As a dynamic food and biofluid, future study may elucidate how EVs vary over i) early, 
transitional and mature milk production periods, ii) course of lactation (fore vs. hind milk), and 
iii) time-of-day variation. This method can be used to elucidate the role of human milk EVs in 
neonatal health and immune system development, and for applications of formula and human 













5. Fatty acids and EVs in human milk: Global discussion, conclusions, and 
future work  
Discussion 
 
The overarching goals of this project were to correlate the fatty acid composition of 
human milk and human milk EVs to infant development (Cognitive, Behavioral, and Motor) 
outcomes reported by the Bayley Scales of Infant Development (BSID-III). However, the latter 
objective was not feasible due to the lack of a suitable method to isolate EVs from small volumes 
(<2 mL) of human milk. Thus, in order to carry out this hypothesis, the following objectives 
were investigated instead: i) whether essential fatty acids correlated to BSID-III developmental 
outcomes, and ii) whether there was a consistent method to isolate EVs from human milk. Both 
objectives investigated in the present study were novel and resulted in novel research findings. 
Specifically, it was found that ARA was inversely correlated to Bayley Cognitive Composite 
scores, and EVs were able to be successfully isolated from human milk. EV isolation was also 
validated according to the criteria of the International Society of Extracellular Vesicles (Théry et 
al., 2018).  
The present research is significant, because it represents the possibility of implementing 
modifiable changes that can confer long term benefits. Many predictors of long term health, such 
as genetics and socioeconomic status cannot be modified. However, nutrition is unique in that it 
is a modifiable factor that can be controlled from infancy onwards. Although public health 
disparities may prevent lactating mothers from accessing recommended nutrition, the present 
research also pertains to the optimization of commercial infant formula products. Even if parents 




nutritional guidelines, associating fatty acids and EVs with infant development will facilitate 
product development for commercial infant formula products that confer the developmental 
benefits associated with human milk.   
Bioactive compounds in human milk, such as the milk fat globule membrane (MFGM) 
have already been extensively studied in relation to infant nutrition. MFGM acts as a natural 
emulsifier to prevent the fat molecules from coalescing in milk and against enzymatic action 
(Singh, 2006). Various nutritional benefits, such as the reduction of necrotizing enterocolitis and 
neonatal gut maturation have been associated with MFGM (Dewettinck et al., 2008). MFGM 
have already been extensively characterized in human milk with respect to the lipid 
(Demmelmair, Koletzko, & panel, 2018), and protein (Yang et al., 2020) composition, and have 
even been incorporated into infant formula (Gallier et al., 2015). However, the relation between 
the composition of other bioactive compounds in human milk, such as EVs, and infant 
development remains unknown. Now that a method to isolate EVs from human milk has been 
validated, this gap in knowledge can be addressed. A consistent method of EV isolation will 
permit structure and functional analyses, which could eventually facilitate the incorporation of 
EVs in infant formula products. Overall, the objectives of the present study were met. Clinical 
research can incorporate this knowledge into product development and nutritional 












Conclusions and Future Work  
 The present study examined the relation between bioactive components in human milk 
and infant developmental outcomes. It was determined if i) essential fatty acids correlated to 
BSID-III developmental outcomes, and ii) whether there was a consistent method to isolate EVs 
from human milk. It was found that ARA was inversely correlated with cognitive outcomes at 12 
months of age. EVs were successfully isolated from a small (< 2 mL) volume of human milk 
using an adapted precipitation method, and were subsequently qualitatively and quantitatively 
characterized. Overall, this work can inform education initiatives to promote optimal infant 
health and development outcomes through maternal nutrition. Future work could also extend 
upon the present study to examine EV composition. With the optimization of a suitable isolation 
method, structural and functional studies can now be performed to assess whether the fatty acid 
composition in EV-enriched fractions of human milk differs significantly from the whole human 
milk, and whether fatty acid composition of EVs relates to infant developmental outcomes. 
Future work could also consider whether maternal FADS genotype correlates to fatty acid 
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